Suggestions
Gregory Stock
CEO, Socratic Sciences; Founding Co-Director, Precision Wellness Center, Mt. Sinai Medical School; Founding CEO Signum Biosciences; Best-Selling Author; Public Speaker
Gregory Stock is a prominent figure in the fields of biophysics, biotechnology, and entrepreneurship. He currently serves as the Chief Executive Officer at Fathm.234 Here's a comprehensive overview of his background and accomplishments:
Education and Academic Background
Gregory Stock holds impressive academic credentials:
- PhD in Biophysics from Johns Hopkins University
- MBA from Harvard Business School, where he was a Baker Scholar and won the Freund-Porter Entrepreneurship award
- BS and MS degrees from Johns Hopkins University12
Professional Experience
Throughout his career, Stock has held various notable positions:
- CEO of Fathm, his current role234
- Former CEO of Signum Biosciences, a biotechnology company focused on developing small-molecule therapeutics1
- Former director of the Program on Medicine, Technology and Society at UCLA's School of Medicine1
- Adjunct Professor in the Department of Genetics2
Entrepreneurial Ventures
Stock has been involved in several entrepreneurial endeavors:
- Co-founder of Signum Biosciences in 20031
- Founding Co-Director of Precision Wellness Center at Mt. Sinai Medical Center5
Research and Expertise
His areas of interest and expertise include:
- Implications of the human genome project
- Molecular genetics and bioinformatics
- Ethical, social, and political implications of life sciences and information technology1
Publications and Public Engagement
Stock is a best-selling author and has been actively involved in public discussions:
- Written extensively on biotechnology's impact on society, medicine, and business
- Organized symposiums and debates on topics such as genome access and embryo genetic manipulation
- Regular speaker at academic, government, and business conferences
- Frequent appearances on media outlets like CNN, PBS, NPR, and the BBC1
Professional Affiliations
He has been associated with various organizations:
- Editorial board member of the American Journal of Bioethics
- Member of the California Advisory Committee on Stem Cells and Reproductive Cloning
- Associate director for the Bioagenda Institute and the Center for Life Science Studies at UC Berkeley1
Gregory Stock's diverse background in biophysics, business, and biotechnology has positioned him as a leading voice in discussions about the future of human genetics and biotechnology's role in society.